Not applicableLooking for participantsNCT06000787What this trial is testingMCT for the Harvard/UCSF ROBIN CenterWho this might be right forGlioma, Childhood BrainstemNeuroblastoma Brigham and Women's Hospital 47
Early research (Phase 1)Temporarily pausedNCT06806228What this trial is testingPhase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)Who this might be right forGlioblastoma MultiformeDiffuse Midline Glioma, H3 K27M-MutantGliosarcoma+2 more Petrov, Andrey 10
Early research (Phase 1)Looking for participantsNCT06860594What this trial is testingTesting the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaWho this might be right forAstrocytoma, IDH-Mutant, Grade 2Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Adult Diffuse Midline Glioma, H3 K27-Mutant+4 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Temporarily pausedNCT05123534What this trial is testingSonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPGWho this might be right forDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma SonALAsense, Inc. 15
Early research (Phase 1)Looking for participantsNCT04732065What this trial is testingONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS TumorsWho this might be right forDiffuse Midline Glioma (DMG)GlioblastomaRecurrent Ependymoma+5 more Sabine Mueller, MD, PhD 208
Early research (Phase 1)Looking for participantsNCT04943848What this trial is testingRHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMGWho this might be right forDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3 K27M-Mutant Ann & Robert H Lurie Children's Hospital of Chicago 36
Early research (Phase 1)Active Not RecruitingNCT05835687What this trial is testingLoc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS TumorsWho this might be right forCentral Nervous System NeoplasmsAtypical Teratoid/Rhabdoid TumorDiffuse Midline Glioma, H3 K27M-Mutant+4 more St. Jude Children's Research Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00492089What this trial is testingBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Meningioma+84 more National Cancer Institute (NCI) 11
Early research (Phase 1)Looking for participantsNCT04196413What this trial is testingGD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)Who this might be right forGlioma of Spinal CordGlioma of Brainstem Stanford University 97
Large-scale testing (Phase 3)UnknownNCT03243461What this trial is testingInternational Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)Who this might be right forGlioblastoma WHO Grade IVDiffuse Midline Glioma Histone 3 K27M WHO Grade IVAnaplastic Astrocytoma WHO Grade III+2 more University of Göttingen 167
Testing effectiveness (Phase 2)Looking for participantsNCT06161974What this trial is testingStudy of Olutasidenib and Temozolomide in HGGWho this might be right forHigh Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more Rigel Pharmaceuticals 60
Early research (Phase 1)Looking for participantsNCT05298995What this trial is testingGD2-CAR T Cells for Pediatric Brain TumoursWho this might be right forBrain Tumor, PediatricMedulloblastoma, ChildhoodEmbryonal Tumor+4 more Bambino Gesù Hospital and Research Institute 54
Early research (Phase 1)Ended earlyNCT04804709What this trial is testingNon-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)Who this might be right forDiffuse Intrinsic Pontine GliomaDiffuse Pontine and Thalamic GliomasDiffuse Midline Glioma, H3 K27M-Mutant Columbia University 5
Testing effectiveness (Phase 2)Looking for participantsNCT05843253What this trial is testingStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantWho this might be right forHigh Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+7 more Nationwide Children's Hospital 120
Early research (Phase 1)Looking for participantsNCT07076498What this trial is testingEngineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care RadiationWho this might be right forGlioma M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT02711137What this trial is testingOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors Incyte Corporation 137
Not applicableStudy completedNCT01878266What this trial is testingProspective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in ChildrenWho this might be right forPediatric Brain Stem Glioma Children's Cancer Hospital Egypt 57357 119
Very early researchLooking for participantsNCT06333899What this trial is testingLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionWho this might be right forHigh Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+6 more Nationwide Children's Hospital 15
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT05259605What this trial is testingObservational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO ClassificationWho this might be right forGliomaGlioneuronal TumorChoroid Plexus Tumor+10 more European Organisation for Research and Treatment of Cancer - EORTC 1,650